Similar Articles
Increased PCSK9 associated with cIMT in AS: A useful marker for subclinical atherosclerosis in patients with ankylosing spondylitis
Ahmet Karakoyun, Yasemin Akkubak, Mevlüt Hakan Göktepe, Pınar Diydem Yılmaz, Cengiz Kadıyoran, Mustafa Oğul, Adem Kucuk
DOI: 10.46497/ArchRheumatol.2024.10625
Issue: Volume 39 - Issue 4 - December 2024
1622
1122
Serum Catestatin Levels and Its Relationship with Disease Activity in Patients with Ankylosing Spondylitis
Tugba Alisik, Yagmur Cagla Reis Altan, Murat Alisik, Baris Nacir
DOI: 10.5152/ArchRheumatol.2025.11014
Issue: Volume 40 - Issue 2 - June 2025
2057
717
A Pilot Study on the Anti-Inflammatory Effects of Tacrolimus in Ankylosing Spondylitis: Evidence from Human Samples and a Murine Model
Sooin Park, Moon-Ju Kim, Yu Jeong Lee, Sung Min Yu, Hae-in Lee, So-Hee Jin, A-ra Choi, Seung Cheol Shim, Eun Jeong Won, Tae-Jong Kim
DOI: 10.5152/ArchRheumatol.2025.11154
Issue: Volume 40 - Issue 2 - June 2025
1761
663
Gut Microbiota Mediator Level and Its Relation to Disease Activity in Ankylosing Spondylitis
Hasan Nasrallah, Özlem Altındağ, Mazlum Serdar Akaltun, Mehmet Akif Bozdayı, Mustafa Örkmez, Elif Balbal, Ali Gür
DOI: 10.5152/ArchRheumatol.2025.11048
Issue: Volume 40 - Issue 3 - September 2025
1072
176